Showing results (701-710 of 804) with videos related to

Sort By:
Pageof 81
Anesthesia and Analgesia|October 11, 2022
Thrombosis-Related Loss of Arterial Lines in the First Wave of COVID-19 and Non-COVID-19 Intensive Care Unit PatientsRebecca L Zon, Lauren E Merz, Kara G Fields, et al.
American Journal of Respiratory Cell and Molecular Biology|December 23, 2008
High-mobility group box 1 contributes to lethality of endotoxemia in heme oxygenase-1-deficient miceRina Takamiya, Chi-Chih Hung, Sean R Hall, et al.
Physiological Reports|August 15, 2014
Folliculin regulates cell-cell adhesion, AMPK, and mTORC1 in a cell-type-specific manner in lung-derived cellsDamir Khabibullin, Douglas A Medvetz, Miguel Pinilla, et al.
Expert Opinion on Therapeutic Targets|June 25, 2021
Defibrotide: potential for treating endothelial dysfunction related to viral and post-infectious syndromesEdward Richardson, David García-Bernal, Eleonora Calabretta, et al.
Blood Advances|January 6, 2022
Inflammasome activation in neutrophils of patients with severe COVID-19Karen Aymonnier, Julie Ng, Laura E Fredenburgh, et al.
Arthritis and Rheumatism|June 16, 2001
A randomized, controlled trial of methotrexate versus placebo in early diffuse sclerodermaJ E Pope, N Bellamy, J R Seibold, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 29, 2021
Dynamic Monitoring of Systemic Biomarkers with Gastric SensorsChristoph Steiger, Nhi V Phan, Hen-Wei Huang, et al.
Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc|January 10, 2008
Bovine spongiform encephalopathy in Sweden: an H-type variantDolores Gavier-Widén, Maria Nöremark, Jan P M Langeveld, et al.
Critical Care Medicine|August 12, 2016
Carbon Monoxide Improves Efficacy of Mesenchymal Stromal Cells During Sepsis by Production of Specialized Proresolving Lipid MediatorsKonstantin Tsoyi, Sean R R Hall, Jesmond Dalli, et al.
Journal of Medicinal Chemistry|February 18, 2005
CoMFA, synthesis, and pharmacological evaluation of (E)-3-(2-carboxy-2-arylvinyl)-4,6-dichloro-1H-indole-2-carboxylic acids: 3-[2-(3-aminophenyl)-2-carboxyvinyl]-4,6-dichloro-1H-indole-2-carboxylic acid, a potent selective glycine-site NMDA receptor antagonistBruce M Baron, Robert J Cregge, Robert A Farr, et al.
Pageof 81